Adil Rashid MD
LightNews LightNews
adilrashid.bsky.social
Adil Rashid MD
@adilrashid.bsky.social
18 followers 95 following 0 posts
Internal Medicine; Kashmir; No hobbies
Posts Replies Media Videos
Reposted by Adil Rashid MD
isaacbogoch.bsky.social
Antibiotic-resistant typhoid infections are a growing global health problem, made worse now by emerging carbapenem resistance.

tinyurl.com/4uy7f6y3 by Thirumoorthy et al.
December 22, 2025 at 2:54 PM
Reposted by Adil Rashid MD
jbrianbyrd.bsky.social
Dan Batlle & I wrote about testing for primary aldosteronism, bringing a critical lens to the usual approach

www.ahajournals.org/doi/full/10....
American Heart Association Journals
www.ahajournals.org
December 22, 2025 at 6:14 PM
Reposted by Adil Rashid MD
fperrywilson.bsky.social
You can get ChatGPT to recommend thalidomide to a pregnant woman.
It's not even hard.
A new study in JAMA Network Open shows just how vulnerable medical AI is to manipulation. 🧵
December 23, 2025 at 1:10 AM
Reposted by Adil Rashid MD
madhupai.bsky.social
2025 was a miserable year for global health

It’s nice see some hopeful things we can look forward to 👇🏾

www.theguardian.com/global-devel...
Five big global health wins in 2025 that will save millions of lives
From HIV to TB, scientists and doctors made breakthroughs in treatment and prevention of some of the world’s deadliest diseases
www.theguardian.com
December 23, 2025 at 10:24 AM
Reposted by Adil Rashid MD
boghuma.bsky.social
Five real global health wins in 2025
1.HPV vaccination scaled faster than expected;
2. measles/rubella eliminated in several countries;
3. long-acting HIV PrEP (lenacapavir) approved;
4. progress on TB vaccines/diagnostics;
5. A promising new antimalarial.
www.theguardian.com/global-devel...
Five big global health wins in 2025 that will save millions of lives
From HIV to TB, scientists and doctors made breakthroughs in treatment and prevention of some of the world’s deadliest diseases
www.theguardian.com
December 23, 2025 at 1:14 PM
Reposted by Adil Rashid MD
lageneral-id.bsky.social
Behind the scenes 🔥🔥 with all the laughs on the latest Febrile Podcast @febrilepodcast.com with @lageneral-id.bsky.social and @bradspellberg.bsky.social #IDSky

player.captivate.fm/episode/dd68...
December 22, 2025 at 4:48 PM
Reposted by Adil Rashid MD
gpollara.bsky.social
Great to see this out: new IDSA guidelines on management of complicated UTI.

Listened to excellent @cmicomms.bsky.social podcast with @angelahuttner.bsky.social @erinmccreary.bsky.social @bwtrautner.bsky.social & Valéry Lavergne earlier this year explaining how it was put together!

#UTISky #IDSky
Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Timing of Intravenous to Oral Antibiot...
Barbara W Trautner, Nicolás W Cortés-Penfield, Kalpana Gupta, Elizabeth B Hirsch, Molly Horstman, Gregory J Moran, Richard Colgan, John C O’Horo, Muhammad
academic.oup.com
December 22, 2025 at 5:39 PM
Reposted by Adil Rashid MD
sethalosporin.bsky.social
Want the full reading list?

See “Essential Publications in Infectious Diseases 2025” link below, with more details on essential literature from this year:

pdf: app.box.com/s/ny7m9d0pdi...

Ppt on request

Thanks for reading and for everything you do.
Important ID publications 2025 Cohen.pdf | Powered by Box
app.box.com
December 22, 2025 at 3:22 PM
Reposted by Adil Rashid MD
hswapnil.medsky.social
The latest #FreelyFiltered episode has dropped
www.nephjc.com/freelyfilter...
With pinch hitters Brian Rifkin and Anna Gaddy
FF 85 Live! From Houston, the #KidneyWk Draft — NephJC
FF 85 Live! From Houston, the #KidneyWk Draft
www.nephjc.com
November 19, 2025 at 2:33 PM
Reposted by Adil Rashid MD
paulsaxmd.bsky.social
The latest in the controversy between 3 vs 2 drugs for HIV treatment -- now in advanced HIV disease, with the DOLCE study. @drlaurajwaters.bsky.social #IDSky #HIVsky blogs.jwatch.org/hiv-id-obser...
Two Drugs, Not Three: The DOLCE Study in Advanced HIV Disease
Three-drug therapy has been the standard of care for HIV therapy for so long it’s difficult to shake the view that it must be more effective than two drugs. This is particularly the case for those wit...
blogs.jwatch.org
September 22, 2025 at 12:32 AM
Reposted by Adil Rashid MD
statsepi.bsky.social
I can't believe we spent 3+ years failing to convince people that yes a Harvard epidemiologist and a Hopkins medic and a Stanford economist can be totally full of shit. Such is the dangerous power of institutional prestige.
September 19, 2025 at 12:58 PM
Reposted by Adil Rashid MD
pulmcrit.bsky.social
NLR isn't perfect, but it's a whole lot better than WBC

it can be an early signal of serious trouble

or, if NLR is normal, it argues against sepsis (look for some other problem)

NLR-blind clinicians will think you're a genius 😆

full discussion of NLR here:
emcrit.org/pulmcrit/nlr/
a woman is holding a crystal ball with the words saw that coming written below her
ALT: a woman is holding a crystal ball with the words saw that coming written below her
media.tenor.com
September 22, 2025 at 1:35 PM
Reposted by Adil Rashid MD
emswami.bsky.social
Time to Ditch Andexanet Alfa?
-ANNEXA-1: No mortality benefit, incr VTE
-Real world data: Rech 2025 (PMID:40700941) no improved outcomes, 9% incr VTE w/ andexanet alfa (NNH = 11)

Mounting evidence that andexanet offers no benefit while increasing complications

youtube.com/shorts/7DGcv...
#EMIMCC
Andexanet Alfa + Thrombembolism #emergencymedicine #criticalcare
YouTube video by EMSwami
youtube.com
September 17, 2025 at 1:38 PM
Reposted by Adil Rashid MD
dingdingpeng.the100.ci
Ever stared at a table of regression coefficients & wondered what you're doing with your life?

Very excited to share this gentle introduction to another way of making sense of statistical models (w @vincentab.bsky.social)
Preprint: doi.org/10.31234/osf...
Website: j-rohrer.github.io/marginal-psy...
Models as Prediction Machines: How to Convert Confusing Coefficients into Clear Quantities Abstract Psychological researchers usually make sense of regression models by interpreting coefficient estimates directly. This works well enough for simple linear models, but is more challenging for more complex models with, for example, categorical variables, interactions, non-linearities, and hierarchical structures. Here, we introduce an alternative approach to making sense of statistical models. The central idea is to abstract away from the mechanics of estimation, and to treat models as “counterfactual prediction machines,” which are subsequently queried to estimate quantities and conduct tests that matter substantively. This workflow is model-agnostic; it can be applied in a consistent fashion to draw causal or descriptive inference from a wide range of models. We illustrate how to implement this workflow with the marginaleffects package, which supports over 100 different classes of models in R and Python, and present two worked examples. These examples show how the workflow can be applied across designs (e.g., observational study, randomized experiment) to answer different research questions (e.g., associations, causal effects, effect heterogeneity) while facing various challenges (e.g., controlling for confounders in a flexible manner, modelling ordinal outcomes, and interpreting non-linear models). Figure illustrating model predictions. On the X-axis the predictor, annual gross income in Euro. On the Y-axis the outcome, predicted life satisfaction. A solid line marks the curve of predictions on which individual data points are marked as model-implied outcomes at incomes of interest. Comparing two such predictions gives us a comparison. We can also fit a tangent to the line of predictions, which illustrates the slope at any given point of the curve. A figure illustrating various ways to include age as a predictor in a model. On the x-axis age (predictor), on the y-axis the outcome (model-implied importance of friends, including confidence intervals). Illustrated are 1. age as a categorical predictor, resultings in the predictions bouncing around a lot with wide confidence intervals 2. age as a linear predictor, which forces a straight line through the data points that has a very tight confidence band and 3. age splines, which lies somewhere in between as it smoothly follows the data but has more uncertainty than the straight line.
August 25, 2025 at 11:49 AM
Reposted by Adil Rashid MD
hswapnil.medsky.social
See this fabulous talk on how to think about podocytopathies from Paola Romagnani

youtu.be/bRMeqaGgA9I?...

#NephGR from a few months ago - she will be doing a plenary at the upcoming #ISNWCN
Personalized Therapy for Podocytopathies with Prof. Paola Romagnani
YouTube video by Ottawa Nephrology
youtu.be
September 11, 2025 at 3:53 PM
Reposted by Adil Rashid MD
pulmcrit.bsky.social
drawing a triglyceride level upstream of a propofol infusion can cause an artificially high triglyceride level (due to contamination w/ propofol)

for a patient on a propofol gtt with an unexpectedly high triglyceride level, consider repeating the lab before switching your sedation strategy #EMIMCC
a man in a black sweater is holding a bottle and has the word wut written on his face
ALT: a man in a black sweater is holding a bottle and has the word wut written on his face
media.tenor.com
July 17, 2025 at 11:43 AM
Reposted by Adil Rashid MD
anandvaidya17.bsky.social
www.acpjournals.org/doi/10.7326/... Confirmatory Testing for Primary Aldosteronism: A Study of Diagnostic Test Accuracy: Annals of Internal Medicine: Vol 178, No 7
www.acpjournals.org
July 17, 2025 at 6:04 PM
Reposted by Adil Rashid MD
hswapnil.medsky.social
We screen everyone referred to our hypertension program for many years now

We don’t refer anyone to endo

Most patients just need Spiro

The occasional peeps need AVS and few need an adrenalectomy

Confirmatory tests are useless
July 17, 2025 at 12:35 AM
Reposted by Adil Rashid MD
alexchangmd.bsky.social
2025 AHA/ACC Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults

08/28/25 @ 12:00 pm – 1:30 pm CDT
Featuring writing committee members and highlights from the
ACC/AHA Committee on Clinical Practice Guidelines
targetbp.org/event/target...
Target BP: Webinar – Target:BP
targetbp.org
July 17, 2025 at 8:43 PM
Reposted by Adil Rashid MD
jonathanrydermd.bsky.social
Excited to be a part of this great group of collaborators on this latest work on blood culture contamination & BCx practices across 52 centers

Tons of credit to Valeria Fabre for leading this group!

#IDSky

journals.asm.org/doi/full/10....
Multicenter evaluation of blood culture contamination and blood cultures practices in US acute care hospitals: time for standardization | Journal of Clinical Microbiology
Blood culture contamination (BCC) is associated with patient harm and unnecessary use of healthcare resources. BCC thresholds have been established; however, multiple BCC definitions exist. There is l...
journals.asm.org
July 17, 2025 at 2:51 PM
Reposted by Adil Rashid MD
jonathanrydermd.bsky.social
New RCT in @cmijournal.bsky.social for #UTISky:

Methenamine vs placebo for recurrent UTI PPx (n=281)

Methenamine ⬇️ antibiotic tx for UTI: IRR 0.75 (95% CI 0.57-1.0, p= 0.049)

But methenamine group had ⬆️ abx use in 6m follow-up after dc'ing

www.clinicalmicrobiologyandinfection.com/article/S119...
Methenamine hippurate as prophylaxis for recurrent urinary tract infections in older women – a triple-blind, randomised, placebo-controlled, phase IV trial (ImpresU).
To investigate the preventive effect of the antiseptic methenamine hippurate on recurrent urinary tract infections (rUTIs) in older women.
www.clinicalmicrobiologyandinfection.com
July 15, 2025 at 2:57 AM
Reposted by Adil Rashid MD
hswapnil.medsky.social
A medical adrenalectomy?

ASIs advance - Baxdrostat in primary aldosteronism now www.nejm.org/doi/full/10.... n = 15 single arm trial from @adinaturcu.bsky.social and @astra-zeneca.bsky.social in @nejm.org

~ 25/10 mm Hg BP lowering and impressive aldosterone level drop

#Hypertension #EndoSky
Efficacy and Side-Effect Profile of Baxdrostat in Patients with Primary Aldosteronism.
July 14, 2025 at 11:03 AM
Reposted by Adil Rashid MD
kidneyboy.bsky.social
The latest episode of @freelyfiltered.bsky.social is outstanding. If you are confused about target trial emulation and think of it as a statistical black box, I encourage you to take a listen. @jordybc.bsky.social and Ed Fu do a brilliant job of explaining it.

www.nephjc.com/freelyfilter...
FF 81 Metformin Termination as explored by Target Trial Emulation — NephJC
Metformin Termination as explored by Target Trial Emulation
www.nephjc.com
July 14, 2025 at 1:00 PM
Reposted by Adil Rashid MD
antoinecreon.bsky.social
🧵1/9
Could we improve kidney care by rethinking who gets referred to a nephrologist?
Our latest study in @ndt-era.bsky.social suggests: yes — if we base it on predicted risk rather than fixed eGFR/ACR cutoffs.
📄 t.co/xVcR8LEnhn
#nephrology #KDIGO #KFRE #NephJC #NephSky #Nephpearls
https://shorturl.at/0CzNq
t.co
July 14, 2025 at 12:06 PM
Reposted by Adil Rashid MD
hswapnil.medsky.social
Finerenone gets the HFpEF nod from FDA - as expected

NephJC coverage of FINEHEARTS www.nephjc.com/news/fineheart

Our editorial on kidney outcomes from FINEARTS: pubmed.ncbi.nlm.nih.gov/39814475/
Re”FINE”ing the role of non steroidal MRAs in Cardio Kidney Metabolic syndrome — NephJC
This week, we will discuss non-steroidal mineralocorticoid antagonist in the multiverse of cardiovascular-kidney-metabolic. What FINEHEART pooled analysis would add to what we already learned from FID...
www.nephjc.com
July 14, 2025 at 6:40 PM